Symptoms and Early Signs of OMS
At a Glance
Oliver-McFarlane syndrome often appears in early childhood with unusually long eyelashes, sparse scalp or eyebrow hair, night-vision problems, and slowing growth. Developmental and hormone-related effects vary, so eye, growth, and developmental monitoring should be individualized.
While every child with Oliver-McFarlane Syndrome (OMS) has a unique journey, the condition typically reveals itself through a specific pattern of physical signs and developmental changes. Because OMS is part of a spectrum of disorders caused by the PNPLA6 gene, symptoms can vary significantly from one child to another [1][2]. Understanding these early signs can help you work more effectively with your child’s medical team.
The Signature Sign: Trichomegaly
The most striking early feature of OMS is trichomegaly, which is the medical term for eyelashes that are unusually long (often over 12mm), thick, and dark [3]. While these long lashes are a defining hallmark of OMS, they are not unique to this syndrome. Doctors must rule out other potential causes, including:
- Medications: Certain drugs, such as prostaglandin analogues (often used for glaucoma), some cancer treatments (EGFR inhibitors), and certain immune-suppressing medications [3][4].
- Other Syndromes: Long lashes can also be seen in other rare genetic conditions, such as Cornelia de Lange, Coffin–Siris, or Kabuki syndrome [3][5].
- Acquired Conditions: In some cases, long lashes can be linked to other health issues like HIV, severe allergic skin conditions (atopic dermatitis), or certain connective tissue diseases [3][6].
In OMS, trichomegaly is typically present from birth or very early childhood and is often accompanied by sparse hair on the scalp and eyebrows [7].
Vision Changes: Chorioretinal Degeneration
One of the most significant symptoms of OMS is chorioretinal degeneration, a progressive condition that affects the back of the eye. This often begins with nyctalopia, commonly known as night blindness [8].
You might notice your child:
- Becoming fearful or hesitant in low-light settings.
- Bumping into objects at dusk or in dimly lit rooms.
- Having a narrowed field of vision (peripheral vision loss) [7][9].
The eye disease in OMS can be quite severe, with some small reports of PNPLA6-related disease noting visual acuities of 20/200 or lower. However, these are reported ranges, not expected outcomes, and the child’s own examinations and functional-vision assessment are more informative [10]. Because these changes happen inside the eye, they may not be visible to the naked eye. An eye specialist will use tools like Optical Coherence Tomography (OCT) or an Electroretinogram (ERG) to measure how the retina is functioning and track changes over time [10][11].
Growth and Hormone Development
Poor growth is another core feature of OMS. While some babies are born at a typical size, their growth velocity—the speed at which they grow—often slows down significantly in early childhood [7][12].
This slow growth is usually linked to pituitary hormone deficiencies. The pituitary gland may fail to produce enough growth hormone, which is essential for height, or other hormones that trigger puberty later in life [13][14]. In some cases, children may also have hypogonadotropic hypogonadism, which means the body does not produce the hormones needed for sexual development [11].
Neurological and Developmental Variability
The way OMS affects brain development and movement is highly variable.
- Cognitive Development: Some children with OMS have typical intelligence and no cognitive impairment [7]. Others may experience intellectual disabilities ranging from mild to significant [13].
- Motor Skills: Some children may experience delays in reaching milestones like sitting up, crawling, or walking [15].
- Coordination: Ataxia, which is a lack of muscle coordination affecting balance, is not a defining feature of every child with OMS. It is more characteristic of other PNPLA6 phenotypes like Boucher-Neuhäuser, and its presence warrants an individualized neurological assessment [11][16].
Other Potential Signs
While not universal, some infants with OMS may experience respiratory distress shortly after birth [7]. This is a rare or uncertain reported association based on isolated reports. Pulmonary assessment is guided by symptoms or a relevant NICU history, and routine lung surveillance is not required for every child with OMS [7].
Common questions in this guide
What are the early signs of Oliver-McFarlane syndrome in a child?
Do long eyelashes always mean a child has Oliver-McFarlane syndrome?
What vision problems can Oliver-McFarlane syndrome cause?
Why might a child with OMS stop growing as expected?
Does every child with OMS have developmental delay or poor coordination?
How are retinal changes monitored in Oliver-McFarlane syndrome?
Does breathing trouble at birth mean OMS will cause lung problems later?
Get notified when new evidence is published on Trichomegaly-retina pigmentary degeneration-dwarfism syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399 - 2
Neuropathy target esterase activity predicts retinopathy among PNPLA6 disorders.
Liu J, He Y, Lwin C, et al.
bioRxiv : the preprint server for biology 2023; doi:10.1101/2023.06.09.544373.
PMID: 37333224 - 3
Eyelash trichomegaly: a systematic review of acquired and congenital aetiologies of lengthened lashes.
Hutchison DM, Duffens A, Yale K, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(4)):536-546 doi:10.1111/jdv.17877.
PMID: 34919300 - 4
Eyelash trichomegaly complicating pembrolizumab for colorectal cancer.
Alevizopoulos N, Alexandris D
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2025; (31(5)):842-845 doi:10.1177/10781552241313037.
PMID: 39849978 - 5
Eyelash Trichomegaly: A Rare Presenting Feature of Systemic Lupus Erythematosus.
Dalal A, Sharma S, Kumar A, Sharma N
International journal of trichology 2017; (9(2)):79-81 doi:10.4103/ijt.ijt_59_16.
PMID: 28839394 - 6
Eyelash length for the diagnosis of atopic dermatitis and ichthyosis vulgaris in children-a case control study.
Singh M, Pawar M
European journal of pediatrics 2018; (177(6)):955-960 doi:10.1007/s00431-018-3152-8.
PMID: 29675643 - 7
Oliver McFarlane syndrome: two new cases and a review of the literature.
Lisbjerg K, Andersen MKG, Bertelsen M, et al.
Ophthalmic genetics 2021; (42(4)):464-473 doi:10.1080/13816810.2021.1904419.
PMID: 33818269 - 8
[A case of Oliver-McFarlane syndrome caused by PNPLA6 gene mutation].
Shi J, Zhang X, Xu K, et al.
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2023; (59(6)):484-487 doi:10.3760/cma.j.cn112142-20220627-00316.
PMID: 37264580 - 9
Oliver McFarlane syndrome and choroidal neovascularisation: a case report.
Makuloluwa AK, Dodeja R, Georgiou M, et al.
Ophthalmic genetics 2020; (41(5)):451-456 doi:10.1080/13816810.2020.1783689.
PMID: 32586184 - 10
Novel variants in PNPLA6 causing syndromic retinal dystrophy.
Wu S, Sun Z, Zhu T, et al.
Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.
PMID: 33141049 - 11
Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.
Hussain MA, Kumar V, Chapla A, et al.
JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.
PMID: 41356532 - 12
Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.
Xiao P, Gu Y, Qi X, et al.
Frontiers in genetics 2025; (16()):1693876 doi:10.3389/fgene.2025.1693876.
PMID: 41321566 - 13
New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.
Du C, Yu T, Liu S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.
PMID: 41846525 - 14
Fertility outcomes and management of long-term pubertal testosterone replacement sequelae in Oliver-McFarlane syndrome: a case report and literature review.
Moshe S, Dekel Y, Oron G, Kabha M
AME case reports 2026; (10()):116 doi:10.21037/acr-2026-0024.
PMID: 42299415 - 15
Identification of Oliver-McFarlane syndrome caused by novel compound heterozygous variants of PNPLA6.
Liu F, Ji Y, Li G, et al.
Gene 2020; (761()):145027 doi:10.1016/j.gene.2020.145027.
PMID: 32758583 - 16
Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.
Teive HAG, Camargo CHF, Sato MT, et al.
Cerebellum (London, England) 2018; (17(3)):380-385 doi:10.1007/s12311-017-0909-y.
PMID: 29248984
This page is for informational purposes only and does not constitute medical advice about your child's symptoms. Consult your child's medical team, including appropriate eye, hormone, neurological, and genetic specialists, for individualized evaluation.